Pharmaceutical companies manage a delicate balance between an instinctive want to ensure patients can access their medicines via the PBS and commercial realities in a system defined by its power asymmetry.
If companies accept conditional recommendations, they will keep imposing them
August 22, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 22 August
August 22, 2025 - - Podcast -
If companies accept conditional recommendations, they will keep imposing them
August 22, 2025 - - Latest News -
Applications now open for AusBiotech Invest and the Early-Stage Innovation Forum
August 21, 2025 - - Australian Biotech -
Seymour welcomes Medsafe's year-on-year approvals improvement
August 21, 2025 - - Latest News -
We don't need new laws for conditional outcomes, because they are already embedded in the system
August 21, 2025 - - Latest News -
Draft NICE guidance proposes major shake-up of UK diabetes treatment
August 21, 2025 - - Latest News -
The PBAC's 'conditionality' and 'provisional' revolution from 2013 to 2024
August 21, 2025 - - Latest News